Other Hematopoietic | Pediatrics, Phase I-II

A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders

Volunteers
Health Professionals

What is the purpose of this trial?

This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.

Trial with
Washington University School of Medicine
Ages
21 years and younger
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Sharon Huie

sharon.huie@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Lakshmanan Krishnamurti, MD
Professor of Pediatrics (Hematology/Oncology); Chief, Pediatric Hematology and Oncology

Sub-Investigators

Last Updated
07/20/2023
Study HIC
#2000025196